Evidence map›Paper›PMID 22919590›Full record

ReviewFrontiers in cellular and infection microbiology2011

Host evasion by Burkholderia cenocepacia.

Shyamala Ganesan, Umadevi S Sajjan

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. A type VI secretion system inInfection and immunity · 2024
    Article
  4. Article
  5. Frontiers in cellular and infection microbiology · 2024
    Article
  6. Gasdermin D kills bacteria.Microbiological research · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Frontiers in microbiology · 2017
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shyamala GanesanDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI, USA.
Umadevi S Sajjan
Michigan United · US

Funding

Quercetin and Innate Immune Responses in COPDR01AT004793 · NCCIH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SAJJAN, UMADEVI SIVANAPPA · 2008 to 2011
$1.4M
NCCIH NIH HHS AT4793NCCIH NIH HHS R01 AT004793NHLBI NIH HHS HL897720
6 · The paper itself

Abstract

Burkholderia cenocepacia is an opportunistic respiratory pathogen of individuals with cystic fibrosis (CF). Some strains of B. cenocepacia are highly transmissible and resistant to almost all antibiotics. Approximately one-third of B. cenocepacia infected CF patients go on to develop fatal "cepacia syndrome." During the last two decades, substantial progress has been made with regards to evasion of host innate defense mechanisms by B. cenocepacia. Almost all strains of B. cenocepacia have the capacity to survive and replicate intracellularly in both airway epithelial cells and macrophages, which are primary sentinels of the lung and play a pivotal role in clearance of infecting bacteria. Those strains of B. cenocepacia, which express both cable pili and the associated 22 kDa adhesin are also capable of transmigrating across airway epithelium and persist in mouse models of infection. In this review, we will discuss how this type of interaction between B. cenocepacia and host may lead to persistence of bacteria as well as lung inflammation in CF patients.

Indexed as

AnimalsBurkholderia cenocepaciaBurkholderia InfectionsCystic FibrosisCytokinesDisease Models, AnimalEndocytosisHost-Pathogen InteractionsHumansImmunity, InnateInflammation MediatorsLungMiceOpportunistic InfectionsRespiratory MucosaRespiratory Tract InfectionsCytokinesInflammation MediatorsToll-Like Receptorsairway epitheliumbacterial pathogenesiscable pilicystic fibrosisinflammationinnate immunitylung infectionmacrophages

Identifiers

PMID22919590
PMCPMC3417383
OpenAlexW2147722400

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.